These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 18284007

  • 1. Recent advances in the management of hepato-renal syndrome (HRS).
    Fabrizi F, Martin P, Messa P.
    Acta Clin Belg; 2007; 62 Suppl 2():393-6. PubMed ID: 18284007
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Recent advances in our understanding of hepatorenal syndrome.
    Wong F.
    Nat Rev Gastroenterol Hepatol; 2012 May 22; 9(7):382-91. PubMed ID: 22614754
    [Abstract] [Full Text] [Related]

  • 6. [The role of terlipressin in hepatorenal syndrome].
    Forcellini S, Fabbian F.
    G Ital Nefrol; 2010 May 22; 27(5):469-76. PubMed ID: 20922678
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Terlipressin and hepatorenal syndrome: what is important for nephrologists and hepatologists.
    Magan AA, Khalil AA, Ahmed MH.
    World J Gastroenterol; 2010 Nov 07; 16(41):5139-47. PubMed ID: 21049548
    [Abstract] [Full Text] [Related]

  • 10. Hepatorenal syndrome in patients with cirrhosis.
    Moreau R.
    J Gastroenterol Hepatol; 2002 Jul 07; 17(7):739-47. PubMed ID: 12121502
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.
    Moreau R, Lebrec D.
    Hepatology; 2006 Mar 07; 43(3):385-94. PubMed ID: 16496352
    [Abstract] [Full Text] [Related]

  • 15. Review article: pharmacological treatment of hepatorenal syndrome.
    Ginès P, Torre A, Terra C, Guevara M.
    Aliment Pharmacol Ther; 2004 Sep 07; 20 Suppl 3():57-62; discussion 63-4. PubMed ID: 15335404
    [Abstract] [Full Text] [Related]

  • 16. Hepatorenal syndrome. Long-term treatment with terlipressin as a bridge to liver transplantation.
    Ganne-Carrié N, Hadengue A, Mathurin P, Durand F, Erlinger S, Benhamou JP.
    Dig Dis Sci; 1996 Jun 07; 41(6):1054-6. PubMed ID: 8654133
    [Abstract] [Full Text] [Related]

  • 17. [Hepatorenal syndrome: diagnosis, treatment and prevention].
    Egerod Israelsen M, Gluud LL, Bendtsen F, Møller S, Krag AA.
    Ugeskr Laeger; 2013 May 27; 175(22):1562-6. PubMed ID: 23721840
    [Abstract] [Full Text] [Related]

  • 18. Reversal of hepatorenal syndrome in cirrhotic patients with terlipressin plus albumin. First experience in Mexico.
    Muñoz LE, Alcalá EG, Cordero P, Martínez MA, Vázquez NY, Galindo S, Mendoza E, Segura JJ.
    Ann Hepatol; 2009 May 27; 8(3):207-11. PubMed ID: 19841499
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Results of pretransplant treatment of hepatorenal syndrome with terlipressin.
    Solà E, Cárdenas A, Ginès P.
    Curr Opin Organ Transplant; 2013 Jun 27; 18(3):265-70. PubMed ID: 23652609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.